Silence Therapeutics plc (SLN)
NASDAQ: SLN · Real-Time Price · USD
6.38
-0.25 (-3.77%)
Mar 19, 2026, 4:00 PM EDT - Market closed
Silence Therapeutics Employees
Silence Therapeutics had 88 employees as of December 31, 2025. The number of employees decreased by 28 or -24.14% compared to the previous year.
Employees
88
Change (1Y)
-28
Growth (1Y)
-24.14%
Revenue / Employee
$6,352
Profits / Employee
-$1,006,955
Market Cap
301.35M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 88 | -28 | -24.14% |
| Dec 31, 2024 | 116 | 7 | 6.42% |
| Dec 31, 2023 | 109 | -13 | -10.66% |
| Dec 31, 2022 | 122 | 17 | 16.19% |
| Dec 31, 2021 | 105 | 40 | 61.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Bicycle Therapeutics | 305 |
| Puma Biotechnology | 179 |
| AC Immune | 172 |
| Neurogene | 107 |
| Armata Pharmaceuticals | 60 |
| Immuneering | 53 |
| NovaBridge Biosciences | 32 |
| Immix Biopharma | 21 |
SLN News
- 14 days ago - Silence Therapeutics Highlights Recent Business Achievements and Reports Fourth Quarter and Full Year 2025 Financial Results - Business Wire
- 3 months ago - Silence Therapeutics Announces Leadership Changes - Business Wire
- 4 months ago - Silence Therapeutics: Divesiran Targets High-Burden PV - Seeking Alpha
- 4 months ago - Silence Therapeutics to Participate in Fireside Chat at Jefferies Global Healthcare Conference - Business Wire
- 4 months ago - Silence Therapeutics Reports Third Quarter 2025 Financial Results and Recent Business Highlights - Business Wire
- 5 months ago - Silence Therapeutics Completes Enrollment in SANRECO Phase 2 Study of Divesiran for Polycythemia Vera (PV) - Business Wire
- 6 months ago - Silence Therapeutics Plc (SLN) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript - Seeking Alpha
- 7 months ago - Silence Therapeutics to Participate in September Investor Conferences - Business Wire